A network-based biomarker approach for molecular investigation and diagnosis of lung cancer

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Wang, Yu Chao ^a   Chen, Bor Sen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER SCREENING; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER NETWORK; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; CELL MOTION; CELL PROLIFERATION; GENETIC DATABASE; GENETICS; LUNG TUMOR; METABOLISM; METHODOLOGY; SMOKING;

BIOLOGICAL MARKERS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DATABASES, GENETIC; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; PROTEIN INTERACTION MAPPING; SMOKING; SYSTEMS BIOLOGY;

EID: 78650897194     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-2     Document Type: Article

References (77)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. The rising burden of cancer in the developing world. P Kanavos, Ann Oncol 2006 17 Suppl 8 & 22iii15 viii23 10.1093/annonc/mdl983 16801335
3. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. A Spira JE Beane V Shah K Steiling G Liu F Schembri S Gilman YM Dumas P Calner P Sebastiani S Sridhar J Beamis C Lamb T Anderson N Gerry J Keane ME Lenburg JS Brody, Nat Med 2007 13 361 366 10.1038/nm1556 17334370
4. The new World Health Organization classification of lung tumours. E Brambilla WD Travis TV Colby B Corrin Y Shimosato, Eur Respir J 2001 18 1059 1068 10.1183/09031936.01.00275301 11829087
5. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. SA Khuder, Lung Cancer 2001 31 139 148 10.1016/S0169-5002(00) 00181-1 11165392
6. Effects of cigarette smoke on the human airway epithelial cell transcriptome. A Spira J Beane V Shah G Liu F Schembri X Yang J Palma JS Brody, Proc Natl Acad Sci USA 2004 101 10143 10148 10.1073/pnas.0401422101 15210990 (Pubitemid 38891209)
7. Tobacco smoke carcinogens and lung cancer. SS Hecht, J Natl Cancer Inst 1999 91 1194 1210 10.1093/jnci/91.14.1194 10413421
8. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. H Takahashi H Ogata R Nishigaki DH Broide M Karin, Cancer Cell 2010 17 89 97 10.1016/j.ccr.2009.12.008 20129250
9. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. TR Golub DK Slonim P Tamayo C Huard M Gaasenbeek JP Mesirov H Coller ML Loh JR Downing MA Caligiuri CD Bloomfield ES Lander, Science 1999 286 531 537 10.1126/science.286.5439.531 10521349
10. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. AA Alizadeh MB Eisen RE Davis C Ma IS Lossos A Rosenwald JC Boldrick H Sabet T Tran X Yu JI Powell L Yang GE Marti T Moore J Hudson Jr L Lu DB Lewis R Tibshirani G Sherlock WC Chan TC Greiner DD Weisenburger JO Armitage R Warnke R Levy W Wilson MR Grever JC Byrd D Botstein PO Brown, et al. Nature 2000 403 503 511 10.1038/35000501 10676951
11. Role of biomarkers for early detection of lung cancer and chemoprevention. FR Hirsch DT Merrick WA Franklin, Eur Respir J 2002 19 1151 1158 10.1183/09031936.02.00294102 12108871
12. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. L Ein-Dor O Zuk E Domany, Proc Natl Acad Sci USA 2006 103 5923 5928 10.1073/pnas.0601231103 16585533
13. The hallmarks of cancer. D Hanahan RA Weinberg, Cell 2000 100 57 70 10.1016/S0092-8674(00)81683-9 10647931
14. Cancer genes and the pathways they control. B Vogelstein KW Kinzler, Nat Med 2004 10 789 799 10.1038/nm1087 15286780
15. Network-based classification of breast cancer metastasis. HY Chuang E Lee YT Liu D Lee T Ideker, Mol Syst Biol 2007 3 140 10.1038/msb4100180 17940530
16. Disease candidate gene identification and prioritization using protein interaction networks. J Chen BJ Aronow AG Jegga, BMC Bioinformatics 2009 10 73 10.1186/1471-2105-10-73 19245720
17. An integrative -omics approach to identify functional sub-networks in human colorectal cancer. RK Nibbe M Koyuturk MR Chance, PLoS Comput Biol 2010 6 1000639 10.1371/journal.pcbi.1000639 20090827
18. Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. RK Nibbe S Markowitz L Myeroff R Ewing MR Chance, Mol Cell Proteomics 2009 8 827 845 10.1074/mcp.M800428-MCP200 19098285
19. Associating genes and protein complexes with disease via network propagation. O Vanunu O Magger E Ruppin T Shlomi R Sharan, PLoS Comput Biol 2010 6 1000641 10.1371/journal.pcbi.1000641 20090828
20. Dynamic modularity in protein interaction networks predicts breast cancer outcome. IW Taylor R Linding D Warde-Farley Y Liu C Pesquita D Faria S Bull T Pawson Q Morris JL Wrana, Nat Biotechnol 2009 27 199 204 10.1038/nbt.1522 19182785
21. Genomic analysis of regulatory network dynamics reveals large topological changes. NM Luscombe MM Babu H Yu M Snyder SA Teichmann M Gerstein, Nature 2004 431 308 312 10.1038/nature02782 15372033
22. Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses. SK Yang YC Wang CC Chao YJ Chuang CY Lan BS Chen, BMC Med Genomics 2010 3 19 10.1186/1755-8794-3-19 20497537
23. Predicting disease genes using protein-protein interactions. M Oti B Snel MA Huynen HG Brunner, J Med Genet 2006 43 691 698 10.1136/jmg.2006.041376 16611749
24. Global screening of potential Candida albicans biofilm-related transcription factors via network comparison. YC Wang CY Lan WP Hsieh LA Murillo N Agabian BS Chen, BMC Bioinformatics 2010 11 53 10.1186/1471-2105-11-53 20102611
25. BioGRID: a general repository for interaction datasets. C Stark B-J Breitkreutz T Reguly L Boucher A Breitkreutz M Tyers, Nucl Acids Res 2006 34 535 539 10.1093/nar/gkj109 16381927
26. Development of human protein reference database as an initial platform for approaching systems biology in humans. S Peri JD Navarro R Amanchy TZ Kristiansen CK Jonnalagadda V Surendranath V Niranjan B Muthusamy TK Gandhi M Gronborg N Ibarrola N Deshpande K Shanker HN Shivashankar BP Rashmi MA Ramya Z Zhao KN Chandrika N Padma HC Harsha AJ Yatish MP Kavitha M Menezes DR Choudhury S Suresh N Ghosh R Saravana S Chandran S Krishna M Joy, et al. Genome Res 2003 13 2363 2371 10.1101/gr.1680803 14525934
27. System modeling and identification. R Johansson, Englewood Cliffs, NJ: Prentice Hall 1993
28. Identification of transcription factor cooperativity via stochastic system model. YH Chang YC Wang BS Chen, Bioinformatics 2006 22 2276 2282 10.1093/bioinformatics/btl380 16844711
29. A new look at the statistical model identification. H Akaike, IEEE Transactions on Automatic Control 1974 19 716 723 10.1109/TAC.1974.1100705
30. Principles of biostatistics. M Pagano K Gauvreau, Pacific Grove, CA: Duxbury 2 2000
31. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. S Vicent JM Lopez-Picazo G Toledo MD Lozano W Torre C Garcia-Corchon C Quero JC Soria S Martin-Algarra RG Manzano LM Montuenga, Br J Cancer 2004 90 1047 1052 10.1038/sj.bjc.6601644 14997206
32. Relationship of activated extracellular signal-regulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma. K Hu YH Gan SL Li Y Gao DC Wu CY Wang GY Yu, Oncol Rep 2009 21 137 143 19082454
33. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. JM Kyriakis J Avruch, Physiol Rev 2001 81 807 869 11274345
34. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. JJ Ventura S Tenbaum E Perdiguero M Huth C Guerra M Barbacid M Pasparakis AR Nebreda, Nat Genet 2007 39 750 758 10.1038/ng2037 17468755
35. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Y Shi J Massague, Cell 2003 113 685 700 10.1016/S0092-8674(03)00432-X 12809600
36. TGF-beta and cancer. B Bierie HL Moses, Cytokine Growth Factor Rev 2006 17 29 40 10.1016/j.cytogfr.2005.09.006 16289860
37. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. EM Langenfeld Y Kong J Langenfeld, Oncogene 2006 25 685 692 10.1038/sj.onc.1209110 16247476
38. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. E Zwick J Bange A Ullrich, Endocr Relat Cancer 2001 8 161 173 10.1677/erc.0.0080161 11566607
39. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC. CJ Langer, Int J Radiat Oncol Biol Phys 2004 58 991 1002 10.1016/j.ijrobp.2003.09.099 14967461
40. Somatic mutations affect key pathways in lung adenocarcinoma. L Ding G Getz DA Wheeler ER Mardis MD McLellan K Cibulskis C Sougnez H Greulich DM Muzny MB Morgan L Fulton RS Fulton Q Zhang MC Wendl MS Lawrence DE Larson K Chen DJ Dooling A Sabo AC Hawes H Shen SN Jhangiani LR Lewis O Hall Y Zhu T Mathew Y Ren J Yao SE Scherer K Clerc, et al. Nature 2008 455 1069 1075 10.1038/nature07423 18948947
41. Lung cancer. RS Herbst JV Heymach SM Lippman, N Engl J Med 2008 359 1367 1380 10.1056/NEJMra0802714 18815398
42. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. C Behrens HY Lin JJ Lee MG Raso WK Hong II Wistuba R Lotan, Clin Cancer Res 2008 14 6014 6022 10.1158/1078-0432.CCR-08-0167 18829480
43. Insulin receptor expression by human prostate cancers. ME Cox ME Gleave M Zakikhani RH Bell E Piura E Vickers M Cunningham O Larsson L Fazli M Pollak, Prostate 2009 69 33 40 10.1002/pros.20852 18785179
44. Mutations and deletions of the CBP gene in human lung cancer. M Kishimoto T Kohno K Okudela A Otsuka H Sasaki C Tanabe T Sakiyama C Hirama I Kitabayashi JD Minna S Takenoshita J Yokota, Clin Cancer Res 2005 11 512 519 15701835
45. Mining the Wnt pathway for cancer therapeutics. N Barker H Clevers, Nat Rev Drug Discov 2006 5 997 1014 10.1038/nrd2154 17139285
46. Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma. MA Imai Y Oda M Oda I Nakanishi E Kawahara, J Cancer Res Clin Oncol 2004 130 320 326 10.1007/s00432-003-0538-3 14997382
47. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. M Zajac-Kaye, Lung Cancer 2001 34 Suppl 2 43 46 10.1016/S0169-5002(01)00343-9 11720740
48. Roles of Fyn in pancreatic cancer metastasis. ZY Chen L Cai P Bie SG Wang Y Jiang JH Dong XW Li, J Gastroenterol Hepatol 2010 25 293 301 10.1111/j.1440-1746.2009.06021.x 19968749
49. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells. DJ Vander Griend J D'Antonio B Gurel L Antony AM Demarzo JT Isaacs, Prostate 2010 70 90 99 10.1002/pros.21043 19790235
50. Hormonal carcinogenesis. BE Henderson HS Feigelson, Carcinogenesis 2000 21 427 433 10.1093/carcin/21.3.427 10688862
51. Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer. LA Byers B Sen B Saigal L Diao J Wang M Nanjundan T Cascone GB Mills JV Heymach FM Johnson, Clin Cancer Res 2009 15 6852 6861 10.1158/1078-0432.CCR-09-0767 19861436
52. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Z Li J Zhao Y Du HR Park SY Sun L Bernal-Mizrachi A Aitken FR Khuri H Fu, Proc Natl Acad Sci USA 2008 105 162 167 10.1073/pnas.0710905105 18162532
53. 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. B Wang K Liu HY Lin N Bellam S Ling WC Lin, Mol Cell Biol 2010 30 1508 1527 10.1128/MCB.01335-09 20086099
54. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. MI Ruiz Gallegos K Floor P Roepman JA Rodriguez GA Meijer WJ Mooi E Jassem J Niklinski T Muley N van Zandwijk EF Smit K Beebe L Neckers B Ylstra G Giaccone, PLoS One 2008 3 0001722 10.1371/journal.pone.0001722 18320023
55. p53 mutations in human cancers. M Hollstein D Sidransky B Vogelstein CC Harris, Science 1991 253 49 53 10.1126/science.1905840 1905840
56. Inflammation and cancer. LM Coussens Z Werb, Nature 2002 420 860 867 10.1038/nature01322 12490959
57. NF-kappaB activation in development and progression of cancer. J Inoue J Gohda T Akiyama K Semba, Cancer Sci 2007 98 268 274 10.1111/j.1349-7006.2007. 00389.x 17270016
58. Insights into the functions of BRCA1 and BRCA2. PL Welcsh KN Owens MC King, Trends Genet 2000 16 69 74 10.1016/S0168-9525(99)01930-7 10652533
59. Overexpression of Sp1 transcription factor induces apoptosis. E Deniaud J Baguet AL Mathieu G Pages J Marvel Y Leverrier, Oncogene 2006 25 7096 7105 10.1038/sj.onc.1209696 16715126
60. Akt regulates growth by directly phosphorylating Tsc2. CJ Potter LG Pedraza T Xu, Nat Cell Biol 2002 4 658 665 10.1038/ncb840 12172554
61. Response of cancer cells to molecular interruption of the CK2 signal. H Wang A Davis S Yu K Ahmed, Mol Cell Biochem 2001 227 167 174 10.1023/A:1013112908734 11827168
62. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. KA West IR Linnoila SA Belinsky CC Harris PA Dennis, Cancer Res 2004 64 446 451 10.1158/0008-5472.CAN-03-3241 14744754
63. Integrin-regulated FAK-Src signaling in normal and cancer cells. SK Mitra DD Schlaepfer, Curr Opin Cell Biol 2006 18 516 523 10.1016/j.ceb.2006.08.011 16919435
64. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. GW McLean NO Carragher E Avizienyte J Evans VG Brunton MC Frame, Nat Rev Cancer 2005 5 505 515 10.1038/nrc1647 16069815
65. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. H Liu DC Radisky CM Nelson H Zhang JE Fata RA Roth MJ Bissell, Proc Natl Acad Sci USA 2006 103 4134 4139 10.1073/pnas.0511342103 16537497
66. Phospholipase Cgamma1 is required for metastasis development and progression. G Sala F Dituri C Raimondi S Previdi T Maffucci M Mazzoletti C Rossi M Iezzi R Lattanzio M Piantelli S Iacobelli M Broggini M Falasca, Cancer Res 2008 68 10187 10196 10.1158/0008-5472.CAN-08-1181 19074886
67. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. X Deng SH Tannehill-Gregg MV Nadella G He A Levine Y Cao TJ Rosol, Clin Exp Metastasis 2007 24 107 119 10.1007/s10585-007-9059-9 17370040
68. The emerging complexity of protein ubiquitination. D Komander, Biochem Soc Trans 2009 37 937 953 10.1042/BST0370937 19754430
69. Integrated cellular network of transcription regulations and protein-protein interactions. YC Wang BS Chen, BMC Syst Biol 2010 4 20 10.1186/1752-0509-4-99 20211003
70. An evaluation of human protein-protein interaction data in the public domain. S Mathivanan B Periaswamy TK Gandhi K Kandasamy S Suresh R Mohmood YL Ramachandra A Pandey, BMC Bioinformatics 2006 7 Suppl 5 19 10.1186/1471-2105-7- S5-S19 17254303
71. Classification of microarray data using gene networks. F Rapaport A Zinovyev M Dutreix E Barillot JP Vert, BMC Bioinformatics 2007 8 35 10.1186/1471-2105-8-35 17270037
72. A hypergraph-based learning algorithm for classifying gene expression and arrayCGH data with prior knowledge. Z Tian T Hwang R Kuang, Bioinformatics 2009 25 2831 2838 10.1093/bioinformatics/btp467 19648139
73. From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. A Petrelli S Giordano, Curr Med Chem 2008 15 422 432 10.2174/092986708783503212 18288997
74. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. MG Kris RB Natale RS Herbst TJ Lynch Jr D Prager CP Belani JH Schiller K Kelly H Spiridonidis A Sandler KS Albain D Cella MK Wolf SD Averbuch JJ Ochs AC Kay, JAMA 2003 290 2149 2158 10.1001/jama.290.16.2149 14570950 (Pubitemid 37432975)
75. Network-based drugs and biomarkers. JT Erler R Linding, J Pathol 2010 220 290 296 19921715
76. Multi-target therapeutics: when the whole is greater than the sum of the parts. GR Zimmermann J Lehar CT Keith, Drug Discov Today 2007 12 34 42 10.1016/j.drudis.2006.11.008 17198971
77. Cytoscape: a software environment for integrated models of biomolecular interaction networks. P Shannon A Markiel O Ozier NS Baliga JT Wang D Ramage N Amin B Schwikowski T Ideker, Genome Res 2003 13 2498 2504 10.1101/gr.1239303 14597658